About: Fenofibrate/simvastatin

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Fenofibrate/simvastatin, sold under the brand name Cholib, is a fixed-dose combination medication used to treat abnormal blood lipid levels when used in combination with a low-fat diet and exercise. It contains fenofibrate and simvastatin. It was approved for use in the European Union in August 2013.

Property	Value
dbo:abstract	Fenofibrate/simvastatin, sold under the brand name Cholib, is a fixed-dose combination medication used to treat abnormal blood lipid levels when used in combination with a low-fat diet and exercise. It contains fenofibrate and simvastatin. It was approved for use in the European Union in August 2013. (en)
dbo:alternativeName	Cholib (en)
dbo:casNumber	2447635-10-9
dbo:kegg	D10857
dbo:wikiPageExternalLink	https://druginfo.nlm.nih.gov/drugportal/name/fenofibrate https://druginfo.nlm.nih.gov/drugportal/name/simvastatin
dbo:wikiPageID	63298661 (xsd:integer)
dbo:wikiPageLength	5189 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1071692698 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Dyslipidemia dbc:Carboxylate_esters dbc:Chloroarenes dbc:Lactones dbc:Prodrugs dbc:Secondary_alcohols dbr:Oral_administration dbc:17β-Hydroxysteroid_dehydrogenase_inhibitors dbr:Simvastatin dbr:Statin dbr:Triglyceride dbc:Tetrahydropyrans dbc:Benzophenones dbc:Neuroprotective_agents dbc:2-Methyl-2-phenoxypropanoic_acid_derivatives dbr:Fenofibrate dbc:Statins dbc:Combination_drugs dbc:Isopropyl_esters dbr:Fibrate dbr:Fixed-dose_combination dbr:Indicated
dbp:atcPrefix	10.0
dbp:atcSuffix	BA04 (en)
dbp:casNumber	2447635 (xsd:integer)
dbp:class	dbr:Statin dbr:Fibrate
dbp:component	Simvastatin (en) Fenofibrate (en)
dbp:kegg	D10857 (en)
dbp:legalEu	Rx-only (en)
dbp:routesOfAdministration	dbr:Oral_administration
dbp:tradename	Cholib (en)
dbp:type	combo (en)
dbp:wikiPageUsesTemplate	dbt:Cite_journal dbt:Cite_web dbt:Infobox_drug dbt:PPAR_modulators dbt:Portal_bar dbt:Reflist dbt:See_also dbt:Use_dmy_dates dbt:Cardiovascular-drug-stub dbt:Lipid_modifying_agents
dcterms:subject	dbc:Carboxylate_esters dbc:Chloroarenes dbc:Lactones dbc:Prodrugs dbc:Secondary_alcohols dbc:17β-Hydroxysteroid_dehydrogenase_inhibitors dbc:Tetrahydropyrans dbc:Benzophenones dbc:Neuroprotective_agents dbc:2-Methyl-2-phenoxypropanoic_acid_derivatives dbc:Statins dbc:Combination_drugs dbc:Isopropyl_esters
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug
rdfs:comment	Fenofibrate/simvastatin, sold under the brand name Cholib, is a fixed-dose combination medication used to treat abnormal blood lipid levels when used in combination with a low-fat diet and exercise. It contains fenofibrate and simvastatin. It was approved for use in the European Union in August 2013. (en)
rdfs:label	Fenofibrate/simvastatin (en)
rdfs:seeAlso	dbr:Fenofibrate
owl:sameAs	wikidata:Fenofibrate/simvastatin https://global.dbpedia.org/id/BxMi6
prov:wasDerivedFrom	wikipedia-en:Fenofibrate/simvastatin?oldid=1071692698&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Fenofibrate/simvastatin
is dbo:wikiPageRedirects of	dbr:Cholib
is dbo:wikiPageWikiLink of	dbr:Cholib dbr:ATC_code_C10
is foaf:primaryTopic of	wikipedia-en:Fenofibrate/simvastatin

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.

About: Fenofibrate/simvastatin

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.